Viewing StudyNCT04513379



Ignite Creation Date: 2024-05-06 @ 3:05 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04513379
Status: UNKNOWN
Last Update Posted: 2020-08-14
First Post: 2020-08-12

Brief Title: Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIVTB Co-infected Patients
Sponsor: Shanghai Public Health Clinical Center
Organization: Shanghai Public Health Clinical Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-01
Start Date Type: ESTIMATED
Primary Completion Date: 2022-10-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-01-31
Completion Date Type: ESTIMATED
First Submit Date: 2020-08-12
First Submit QC Date: August 12 2020
Study First Post Date: 2020-08-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-08-12
Last Update Post Date: 2020-08-14
Last Update Post Date Type: ACTUAL